In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique

Aims: Medicinal plants are increasingly being projected as suitable alternative sources of antiviral agents. The development of a suitable in vitro pharmacodynamic screening technique could contribute to rapid identification of potential bioactive plants and also to the standardization and/or pharma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of applied microbiology 2005-01, Vol.99 (6), p.1346-1355
Hauptverfasser: Esimone, C.O, Grunwald, T, Wildner, O, Nchinda, G, Tippler, B, Proksch, P, Uberla, K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1355
container_issue 6
container_start_page 1346
container_title Journal of applied microbiology
container_volume 99
creator Esimone, C.O
Grunwald, T
Wildner, O
Nchinda, G
Tippler, B
Proksch, P
Uberla, K
description Aims: Medicinal plants are increasingly being projected as suitable alternative sources of antiviral agents. The development of a suitable in vitro pharmacodynamic screening technique could contribute to rapid identification of potential bioactive plants and also to the standardization and/or pharmacokinetic-pharmacodynamic profiling of the bioactive components. Methods and Results: Recombinant viral vectors (lentiviral, retroviral and adenoviral) transferring the firefly luciferase gene were constructed and the inhibition of viral vector infectivity by various concentrations of plant extracts was evaluated in HeLa or Hep2 cells by measuring the changes in luciferase activity. Cytotoxicity of the extracts was evaluated in parallel on HeLa or Hep2 cells stably expressing luciferase. Amongst the 15 extracts screened, only the methanol (ME) and the ethyl acetate (ET) fractions of the lichen, Ramalina farinacea specifically reduced lentiviral and adenoviral infectivity in a dose-dependent manner. Further, chromatographic fractionation of ET into four fractions (ET1-ET4) revealed only ET4 to be selectively antiviral with an IC50 in the 20 microgram ml(-1) range. Preliminary mechanistic studies based on the addition of the extracts at different time points in the viral infection cycle (kinetic studies) revealed that the inhibitory activity was highest if extract and vectors were preincubated prior to infection, suggesting that early steps in the lentiviral or adenoviral replication cycle could be the major target of ET4. Inhibition of wild-type HIV-1 was also observed at a 10-fold lower concentration of the extract. Conclusions: The vector-based assay is a suitable in vitro pharmacodynamic evaluation technique for antiviral medicinal plants. The technique has successfully demonstrated the presence of antiviral principles in R. farinacea. Significance and Impact of Study: Potential anti-HIV medicinal plants could rapidly be evaluated with the reported vector-based technique. The lichen, R. farinacea could represent a lead source of antiviral substances and is thus worthy of further studies.
doi_str_mv 10.1111/j.1365-2672.2005.02732.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68842064</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68842064</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5022-cf2ac87e341f8f8d02ff320baee46da729da356597332eac1f9cfb45a8a4c3b73</originalsourceid><addsrcrecordid>eNqNksFu1DAQhi0EoqXwCuAL3BLsseMkBw5VBaWoiAP0bE0cu_UqiRc7WbpvX6e7okfwxSP7-z3jf4YQylnJ8_q4KblQVQGqhhIYq0oGtYDy_hk5_Xvx_DGWRcVqOCGvUtowxgWr1EtywpXgQrL6lLirie78HAPd3mEc0YR-P-HoDbU7HBacfZhocBSn2e98xIGOtvfGTznaDvk00SX56ZYi3Vkzh1h0mGxPMSXc09mau8n_Xuxr8sLhkOyb435Gbr58_nXxtbj-cXl1cX5dmIoBFMYBmqa2QnLXuKZn4JwA1qG1UvVYQ9ujqFTV1kKARcNda1wnK2xQGtHV4ox8OLy7jSGnTbMefTJ2yJXasCStmkYCU_KfIG8bwZWEDDYH0MSQUrROb6MfMe41Z3ptht7o1XO9eq7XZujHZuj7LH17zLF02bUn4dH9DLw_ApgMDi7iZHx64vJ_BRNrDZ8O3B8_2P1_F6C_nX9fo6x_d9A7DBpvY85x8xPWaeB5OGQL4gHiu6_y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19831642</pqid></control><display><type>article</type><title>In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Wiley Online Library All Journals</source><creator>Esimone, C.O ; Grunwald, T ; Wildner, O ; Nchinda, G ; Tippler, B ; Proksch, P ; Uberla, K</creator><creatorcontrib>Esimone, C.O ; Grunwald, T ; Wildner, O ; Nchinda, G ; Tippler, B ; Proksch, P ; Uberla, K</creatorcontrib><description>Aims: Medicinal plants are increasingly being projected as suitable alternative sources of antiviral agents. The development of a suitable in vitro pharmacodynamic screening technique could contribute to rapid identification of potential bioactive plants and also to the standardization and/or pharmacokinetic-pharmacodynamic profiling of the bioactive components. Methods and Results: Recombinant viral vectors (lentiviral, retroviral and adenoviral) transferring the firefly luciferase gene were constructed and the inhibition of viral vector infectivity by various concentrations of plant extracts was evaluated in HeLa or Hep2 cells by measuring the changes in luciferase activity. Cytotoxicity of the extracts was evaluated in parallel on HeLa or Hep2 cells stably expressing luciferase. Amongst the 15 extracts screened, only the methanol (ME) and the ethyl acetate (ET) fractions of the lichen, Ramalina farinacea specifically reduced lentiviral and adenoviral infectivity in a dose-dependent manner. Further, chromatographic fractionation of ET into four fractions (ET1-ET4) revealed only ET4 to be selectively antiviral with an IC50 in the 20 microgram ml(-1) range. Preliminary mechanistic studies based on the addition of the extracts at different time points in the viral infection cycle (kinetic studies) revealed that the inhibitory activity was highest if extract and vectors were preincubated prior to infection, suggesting that early steps in the lentiviral or adenoviral replication cycle could be the major target of ET4. Inhibition of wild-type HIV-1 was also observed at a 10-fold lower concentration of the extract. Conclusions: The vector-based assay is a suitable in vitro pharmacodynamic evaluation technique for antiviral medicinal plants. The technique has successfully demonstrated the presence of antiviral principles in R. farinacea. Significance and Impact of Study: Potential anti-HIV medicinal plants could rapidly be evaluated with the reported vector-based technique. The lichen, R. farinacea could represent a lead source of antiviral substances and is thus worthy of further studies.</description><identifier>ISSN: 1364-5072</identifier><identifier>EISSN: 1365-2672</identifier><identifier>DOI: 10.1111/j.1365-2672.2005.02732.x</identifier><identifier>PMID: 16313407</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adenoviridae Infections - drug therapy ; Adenoviruses, Human - genetics ; Adenoviruses, Human - physiology ; antiviral ; Antiviral Agents - therapeutic use ; antiviral properties ; Biological and medical sciences ; Biological Assay ; Cell Line, Tumor ; cultured cells ; cytotoxicity ; Fundamental and applied biological sciences. Psychology ; Genetic Engineering ; genetic vectors ; Genetic Vectors - administration &amp; dosage ; Genetic Vectors - genetics ; HeLa Cells ; HIV - genetics ; HIV - physiology ; HIV Infections - drug therapy ; human health ; Human immunodeficiency virus ; Human immunodeficiency virus 1 ; Humans ; lichen ; Luciferases - genetics ; Luminescent Measurements ; medicinal plants ; Medicine, African Traditional ; Microbiology ; Nigeria ; pharmacodynamic ; pharmacology ; plant extracts ; Plant Extracts - therapeutic use ; Plants, Medicinal ; Ramalina farinacea ; Retroviridae - genetics ; Retroviridae - physiology ; vector‐based assay</subject><ispartof>Journal of applied microbiology, 2005-01, Vol.99 (6), p.1346-1355</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5022-cf2ac87e341f8f8d02ff320baee46da729da356597332eac1f9cfb45a8a4c3b73</citedby><cites>FETCH-LOGICAL-c5022-cf2ac87e341f8f8d02ff320baee46da729da356597332eac1f9cfb45a8a4c3b73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2672.2005.02732.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2672.2005.02732.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17293032$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16313407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Esimone, C.O</creatorcontrib><creatorcontrib>Grunwald, T</creatorcontrib><creatorcontrib>Wildner, O</creatorcontrib><creatorcontrib>Nchinda, G</creatorcontrib><creatorcontrib>Tippler, B</creatorcontrib><creatorcontrib>Proksch, P</creatorcontrib><creatorcontrib>Uberla, K</creatorcontrib><title>In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique</title><title>Journal of applied microbiology</title><addtitle>J Appl Microbiol</addtitle><description>Aims: Medicinal plants are increasingly being projected as suitable alternative sources of antiviral agents. The development of a suitable in vitro pharmacodynamic screening technique could contribute to rapid identification of potential bioactive plants and also to the standardization and/or pharmacokinetic-pharmacodynamic profiling of the bioactive components. Methods and Results: Recombinant viral vectors (lentiviral, retroviral and adenoviral) transferring the firefly luciferase gene were constructed and the inhibition of viral vector infectivity by various concentrations of plant extracts was evaluated in HeLa or Hep2 cells by measuring the changes in luciferase activity. Cytotoxicity of the extracts was evaluated in parallel on HeLa or Hep2 cells stably expressing luciferase. Amongst the 15 extracts screened, only the methanol (ME) and the ethyl acetate (ET) fractions of the lichen, Ramalina farinacea specifically reduced lentiviral and adenoviral infectivity in a dose-dependent manner. Further, chromatographic fractionation of ET into four fractions (ET1-ET4) revealed only ET4 to be selectively antiviral with an IC50 in the 20 microgram ml(-1) range. Preliminary mechanistic studies based on the addition of the extracts at different time points in the viral infection cycle (kinetic studies) revealed that the inhibitory activity was highest if extract and vectors were preincubated prior to infection, suggesting that early steps in the lentiviral or adenoviral replication cycle could be the major target of ET4. Inhibition of wild-type HIV-1 was also observed at a 10-fold lower concentration of the extract. Conclusions: The vector-based assay is a suitable in vitro pharmacodynamic evaluation technique for antiviral medicinal plants. The technique has successfully demonstrated the presence of antiviral principles in R. farinacea. Significance and Impact of Study: Potential anti-HIV medicinal plants could rapidly be evaluated with the reported vector-based technique. The lichen, R. farinacea could represent a lead source of antiviral substances and is thus worthy of further studies.</description><subject>Adenoviridae Infections - drug therapy</subject><subject>Adenoviruses, Human - genetics</subject><subject>Adenoviruses, Human - physiology</subject><subject>antiviral</subject><subject>Antiviral Agents - therapeutic use</subject><subject>antiviral properties</subject><subject>Biological and medical sciences</subject><subject>Biological Assay</subject><subject>Cell Line, Tumor</subject><subject>cultured cells</subject><subject>cytotoxicity</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic Engineering</subject><subject>genetic vectors</subject><subject>Genetic Vectors - administration &amp; dosage</subject><subject>Genetic Vectors - genetics</subject><subject>HeLa Cells</subject><subject>HIV - genetics</subject><subject>HIV - physiology</subject><subject>HIV Infections - drug therapy</subject><subject>human health</subject><subject>Human immunodeficiency virus</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>lichen</subject><subject>Luciferases - genetics</subject><subject>Luminescent Measurements</subject><subject>medicinal plants</subject><subject>Medicine, African Traditional</subject><subject>Microbiology</subject><subject>Nigeria</subject><subject>pharmacodynamic</subject><subject>pharmacology</subject><subject>plant extracts</subject><subject>Plant Extracts - therapeutic use</subject><subject>Plants, Medicinal</subject><subject>Ramalina farinacea</subject><subject>Retroviridae - genetics</subject><subject>Retroviridae - physiology</subject><subject>vector‐based assay</subject><issn>1364-5072</issn><issn>1365-2672</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNksFu1DAQhi0EoqXwCuAL3BLsseMkBw5VBaWoiAP0bE0cu_UqiRc7WbpvX6e7okfwxSP7-z3jf4YQylnJ8_q4KblQVQGqhhIYq0oGtYDy_hk5_Xvx_DGWRcVqOCGvUtowxgWr1EtywpXgQrL6lLirie78HAPd3mEc0YR-P-HoDbU7HBacfZhocBSn2e98xIGOtvfGTznaDvk00SX56ZYi3Vkzh1h0mGxPMSXc09mau8n_Xuxr8sLhkOyb435Gbr58_nXxtbj-cXl1cX5dmIoBFMYBmqa2QnLXuKZn4JwA1qG1UvVYQ9ujqFTV1kKARcNda1wnK2xQGtHV4ox8OLy7jSGnTbMefTJ2yJXasCStmkYCU_KfIG8bwZWEDDYH0MSQUrROb6MfMe41Z3ptht7o1XO9eq7XZujHZuj7LH17zLF02bUn4dH9DLw_ApgMDi7iZHx64vJ_BRNrDZ8O3B8_2P1_F6C_nX9fo6x_d9A7DBpvY85x8xPWaeB5OGQL4gHiu6_y</recordid><startdate>20050101</startdate><enddate>20050101</enddate><creator>Esimone, C.O</creator><creator>Grunwald, T</creator><creator>Wildner, O</creator><creator>Nchinda, G</creator><creator>Tippler, B</creator><creator>Proksch, P</creator><creator>Uberla, K</creator><general>Blackwell Science Ltd</general><general>Blackwell Science</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050101</creationdate><title>In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique</title><author>Esimone, C.O ; Grunwald, T ; Wildner, O ; Nchinda, G ; Tippler, B ; Proksch, P ; Uberla, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5022-cf2ac87e341f8f8d02ff320baee46da729da356597332eac1f9cfb45a8a4c3b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenoviridae Infections - drug therapy</topic><topic>Adenoviruses, Human - genetics</topic><topic>Adenoviruses, Human - physiology</topic><topic>antiviral</topic><topic>Antiviral Agents - therapeutic use</topic><topic>antiviral properties</topic><topic>Biological and medical sciences</topic><topic>Biological Assay</topic><topic>Cell Line, Tumor</topic><topic>cultured cells</topic><topic>cytotoxicity</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic Engineering</topic><topic>genetic vectors</topic><topic>Genetic Vectors - administration &amp; dosage</topic><topic>Genetic Vectors - genetics</topic><topic>HeLa Cells</topic><topic>HIV - genetics</topic><topic>HIV - physiology</topic><topic>HIV Infections - drug therapy</topic><topic>human health</topic><topic>Human immunodeficiency virus</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>lichen</topic><topic>Luciferases - genetics</topic><topic>Luminescent Measurements</topic><topic>medicinal plants</topic><topic>Medicine, African Traditional</topic><topic>Microbiology</topic><topic>Nigeria</topic><topic>pharmacodynamic</topic><topic>pharmacology</topic><topic>plant extracts</topic><topic>Plant Extracts - therapeutic use</topic><topic>Plants, Medicinal</topic><topic>Ramalina farinacea</topic><topic>Retroviridae - genetics</topic><topic>Retroviridae - physiology</topic><topic>vector‐based assay</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Esimone, C.O</creatorcontrib><creatorcontrib>Grunwald, T</creatorcontrib><creatorcontrib>Wildner, O</creatorcontrib><creatorcontrib>Nchinda, G</creatorcontrib><creatorcontrib>Tippler, B</creatorcontrib><creatorcontrib>Proksch, P</creatorcontrib><creatorcontrib>Uberla, K</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of applied microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Esimone, C.O</au><au>Grunwald, T</au><au>Wildner, O</au><au>Nchinda, G</au><au>Tippler, B</au><au>Proksch, P</au><au>Uberla, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique</atitle><jtitle>Journal of applied microbiology</jtitle><addtitle>J Appl Microbiol</addtitle><date>2005-01-01</date><risdate>2005</risdate><volume>99</volume><issue>6</issue><spage>1346</spage><epage>1355</epage><pages>1346-1355</pages><issn>1364-5072</issn><eissn>1365-2672</eissn><abstract>Aims: Medicinal plants are increasingly being projected as suitable alternative sources of antiviral agents. The development of a suitable in vitro pharmacodynamic screening technique could contribute to rapid identification of potential bioactive plants and also to the standardization and/or pharmacokinetic-pharmacodynamic profiling of the bioactive components. Methods and Results: Recombinant viral vectors (lentiviral, retroviral and adenoviral) transferring the firefly luciferase gene were constructed and the inhibition of viral vector infectivity by various concentrations of plant extracts was evaluated in HeLa or Hep2 cells by measuring the changes in luciferase activity. Cytotoxicity of the extracts was evaluated in parallel on HeLa or Hep2 cells stably expressing luciferase. Amongst the 15 extracts screened, only the methanol (ME) and the ethyl acetate (ET) fractions of the lichen, Ramalina farinacea specifically reduced lentiviral and adenoviral infectivity in a dose-dependent manner. Further, chromatographic fractionation of ET into four fractions (ET1-ET4) revealed only ET4 to be selectively antiviral with an IC50 in the 20 microgram ml(-1) range. Preliminary mechanistic studies based on the addition of the extracts at different time points in the viral infection cycle (kinetic studies) revealed that the inhibitory activity was highest if extract and vectors were preincubated prior to infection, suggesting that early steps in the lentiviral or adenoviral replication cycle could be the major target of ET4. Inhibition of wild-type HIV-1 was also observed at a 10-fold lower concentration of the extract. Conclusions: The vector-based assay is a suitable in vitro pharmacodynamic evaluation technique for antiviral medicinal plants. The technique has successfully demonstrated the presence of antiviral principles in R. farinacea. Significance and Impact of Study: Potential anti-HIV medicinal plants could rapidly be evaluated with the reported vector-based technique. The lichen, R. farinacea could represent a lead source of antiviral substances and is thus worthy of further studies.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>16313407</pmid><doi>10.1111/j.1365-2672.2005.02732.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1364-5072
ispartof Journal of applied microbiology, 2005-01, Vol.99 (6), p.1346-1355
issn 1364-5072
1365-2672
language eng
recordid cdi_proquest_miscellaneous_68842064
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); Wiley Online Library All Journals
subjects Adenoviridae Infections - drug therapy
Adenoviruses, Human - genetics
Adenoviruses, Human - physiology
antiviral
Antiviral Agents - therapeutic use
antiviral properties
Biological and medical sciences
Biological Assay
Cell Line, Tumor
cultured cells
cytotoxicity
Fundamental and applied biological sciences. Psychology
Genetic Engineering
genetic vectors
Genetic Vectors - administration & dosage
Genetic Vectors - genetics
HeLa Cells
HIV - genetics
HIV - physiology
HIV Infections - drug therapy
human health
Human immunodeficiency virus
Human immunodeficiency virus 1
Humans
lichen
Luciferases - genetics
Luminescent Measurements
medicinal plants
Medicine, African Traditional
Microbiology
Nigeria
pharmacodynamic
pharmacology
plant extracts
Plant Extracts - therapeutic use
Plants, Medicinal
Ramalina farinacea
Retroviridae - genetics
Retroviridae - physiology
vector‐based assay
title In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T15%3A26%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20pharmacodynamic%20evaluation%20of%20antiviral%20medicinal%20plants%20using%20a%20vector-based%20assay%20technique&rft.jtitle=Journal%20of%20applied%20microbiology&rft.au=Esimone,%20C.O&rft.date=2005-01-01&rft.volume=99&rft.issue=6&rft.spage=1346&rft.epage=1355&rft.pages=1346-1355&rft.issn=1364-5072&rft.eissn=1365-2672&rft_id=info:doi/10.1111/j.1365-2672.2005.02732.x&rft_dat=%3Cproquest_cross%3E68842064%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19831642&rft_id=info:pmid/16313407&rfr_iscdi=true